Generic Name: Anastrazole Tablets
Femistra Tablet is a medication that contains the active ingredient anastrozole. Anastrozole belongs to a class of drugs known as aromatase inhibitors. It is commonly prescribed to postmenopausal women for the treatment of hormone receptor-positive breast cancer.
The active ingredient in Femistra Tablet is anastrozole, an aromatase inhibitor. Aromatase is an enzyme responsible for the conversion of androgens into estrogen. Anastrozole works by inhibiting this process, thereby lowering estrogen levels in the body.
Femistra is primarily used in the management of breast cancer, specifically hormone receptor-positive breast cancer in postmenopausal women. This type of breast cancer is driven by estrogen, and anastrozole helps to suppress estrogen production.
By reducing estrogen levels, Femistra inhibits the growth of estrogen-sensitive cancer cells. It is often prescribed as part of a comprehensive treatment plan to slow down the progression of the disease and reduce the risk of recurrence.
Anastrozole can be used as adjuvant therapy after surgery or other primary treatments to decrease the risk of cancer recurrence.

• Customer-Centric Solutions: Parshva Agency focuses on delivering tailored private labeling services on a Peer-to-Peer (P2P) basis to meet the unique needs of each client.
• Regulatory Support: The agency is backed by experienced regulatory experts who ensure full compliance with all industry standards, providing peace of mind to clients.
• State-of-the-Art Manufacturing: Partnered with advanced manufacturing facilities that meet WHO-GMP certifications, Parshva Agency emphasizes the importance of modern production techniques.
• Quality and Efficacy: With WHO-GMP certification, the agency guarantees that its products maintain the highest standards of quality and efficacy.
• Reliability: Parshva Agency is committed to providing safe, reliable, and compliant products that meet stringent regulatory guidelines, fostering trust among clients and stakeholders.